FDA Inspection 1028388 — Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.
The FDA completed an inspection of Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A. on July 4, 2017 in Colleretto Giacosa. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Colleretto Giacosa (Italy)